Remodeling Collagen Microenvironment in Liver Using a Biomimetic Nano-Regulator for Reversal of Liver Fibrosis

Liver fibrosis is a progressive histological manifestation that happens in almost all chronic liver diseases. An unabated liver fibrosis may eventually develop into liver cirrhosis or hepatocellular carcinoma. Yet, the strategy for reversal of liver fibrosis is still limited. Herein, a biomimetic nano-regulator (P-ZIF8-cirDNAzyme) is developed to affect both collagen synthesis and degradation in liver to remodel collagen microenvironment. It is found that Zn (II) interference can efficiently inhibit collagen synthesis in activated hepatic stellate cells (aHSC) by inactivating proline 4 hydroxylase and affecting many fibrosis-related signaling pathways. Meanwhile, Zn (II)-dependent circular DNAzymes (cirDNAzymes) are used to efficiently silence tissue inhibitors of metalloproteinase-1, accelerating the degradation of collagen. They act in concert to recover the balance between collagen deposition and degradation. Additionally, ZIF-8-cirDNAzyme is coated by platelet membrane (PM) for precisely targeting aHSC via PM's inflammatory tropism and CD62p-CD44 interaction. In carbon tetrachloride-induced fibrotic mice, P-ZIF-8-cirDNAzyme shows a potent anti-fibrotic effect, greatly reducing the expression of collagen by 73.12% and restoring liver function nearly to normal. This work proposes a prospective platform enabling ion interference and gene silencing, collectively acting in aHSC for reversal of liver fibrosis.

Automated summary

This study developed a biomimetic nano-regulator (P-ZIF8-cirDNAzyme) that can affect collagen synthesis and degradation in the liver to reverse liver fibrosis. Zinc (II) interference inhibits collagen synthesis by inactivating proline 4 hydroxylase and affecting fibrosis-related signaling pathways. Zinc (II)-dependent circular DNAzymes silence tissue inhibitors of metalloproteinase-1, accelerating collagen degradation. The coated P-ZIF-8-cirDNAzyme targets activated hepatic stellate cells (aHSC) with inflammatory tropism and CD62p-CD44 interaction, showing a potent anti-fibrotic effect and restoring liver function in fibrotic mice.